J Scott Wolchko Fate Therapeutics Inc (FATE) insider trading activity

J Scott Wolchko is President and CEO of FATE THERAPEUTICS INC. Currently has a direct ownership of 371,248 shares of FATE, which is worth approximately $742,496. The most recent transaction as insider was on Jul 23, 2021, when has been sold 30,000 shares (Common Stock) at a price of $85.28 per share, resulting in proceeds of $2,558,400. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 371K

0% 3M change

3.73% 12M change

Total Value Held $742,496

J Scott Wolchko Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jul 23 2021	SELL Open market or private sale	$2,558,400 $85.28 p/Share	30,000 Reduced 7.08%	393,793 Common Stock
Jul 23 2021	BUY Exercise of conversion of derivative security	$113,700 $3.79 p/Share	30,000 Added 6.61%	423,793 Common Stock
Jul 22 2021	SELL Open market or private sale	$2,584,800 $86.16 p/Share	30,000 Reduced 7.08%	393,793 Common Stock
Jul 22 2021	BUY Exercise of conversion of derivative security	$81,900 $2.73 p/Share	30,000 Added 6.61%	423,793 Common Stock
May 20 2021	SELL Open market or private sale	$1,543,200 $77.16 p/Share	20,000 Reduced 4.83%	393,793 Common Stock
May 20 2021	BUY Exercise of conversion of derivative security	$96,800 $4.84 p/Share	20,000 Added 4.61%	413,793 Common Stock
Apr 23 2021	SELL Open market or private sale	$2,557,200 $85.24 p/Share	30,000 Reduced 7.08%	393,793 Common Stock
Apr 23 2021	BUY Exercise of conversion of derivative security	$141,900 $4.73 p/Share	30,000 Added 6.61%	423,793 Common Stock
Apr 22 2021	SELL Open market or private sale	$2,566,200 $85.54 p/Share	30,000 Reduced 7.08%	393,793 Common Stock
Apr 22 2021	BUY Exercise of conversion of derivative security	$81,900 $2.73 p/Share	30,000 Added 6.61%	423,793 Common Stock
Feb 18 2021	SELL Open market or private sale	$2,025,600 $101.28 p/Share	20,000 Reduced 4.83%	393,793 Common Stock
Feb 18 2021	BUY Exercise of conversion of derivative security	$132,400 $6.62 p/Share	20,000 Added 4.61%	413,793 Common Stock
Jan 22 2021	SELL Open market or private sale	$2,962,800 $98.76 p/Share	30,000 Reduced 7.08%	393,793 Common Stock
Jan 22 2021	BUY Exercise of conversion of derivative security	$140,400 $4.68 p/Share	30,000 Added 6.61%	423,793 Common Stock
Jan 21 2021	SELL Open market or private sale	$3,107,700 $103.59 p/Share	30,000 Reduced 7.08%	393,793 Common Stock
Jan 21 2021	BUY Exercise of conversion of derivative security	$81,900 $2.73 p/Share	30,000 Added 6.61%	423,793 Common Stock
Jan 20 2021	BUY Grant, award, or other acquisition	-	43,231 Added 9.89%	393,793 Common Stock
Jan 11 2021	SELL Open market or private sale	$950,409 $110.68 p/Share	8,587 Reduced 2.39%	350,562 Common Stock
Jan 08 2021	SELL Open market or private sale	$7,075,191 $116.33 p/Share	60,820 Reduced 14.48%	359,149 Common Stock
Dec 17 2020	SELL Open market or private sale	$1,845,600 $92.28 p/Share	20,000 Reduced 4.55%	419,969 Common Stock
Dec 17 2020	BUY Exercise of conversion of derivative security	$132,400 $6.62 p/Share	20,000 Added 4.35%	439,969 Common Stock
Nov 13 2020	SELL Open market or private sale	$1,530,900 $51.03 p/Share	30,000 Reduced 6.67%	419,969 Common Stock
Nov 13 2020	BUY Exercise of conversion of derivative security	$172,200 $5.74 p/Share	30,000 Added 6.52%	430,123 Common Stock
Nov 12 2020	SELL Open market or private sale	$1,595,400 $53.18 p/Share	30,000 Reduced 6.67%	419,969 Common Stock
Nov 12 2020	BUY Exercise of conversion of derivative security	$81,900 $2.73 p/Share	30,000 Added 6.25%	449,969 Common Stock

JSW

J Scott Wolchko

President and CEO

San Diego, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells FATE shares.

Notify only if

Value

Insider Trading

Get notified when an Fate Therapeutics Inc insider buys or sells FATE shares.

Notify only if

Operation

Value

Type

News

Receive news related to FATE THERAPEUTICS INC

Track Activities on FATE

Account